Sturm L, Muller L, Schultheiss M, Binder B, et al. Proton pump inhibitor therapy is associated with reduced survival following first-time transarterial chemoembolization in patients with hepatocellular carcinoma. Eur J Gastroenterol Hepatol 2020 Dec 14. doi: 10.1097/MEG.0000000000002018.
PMID: 33323760